Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Smith & Nephew Snats (SNN)

Smith & Nephew Snats (SNN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,904,998
  • Shares Outstanding, K 437,775
  • Annual Sales, $ 5,138 M
  • Annual Income, $ 600,000 K
  • 60-Month Beta 0.56
  • Price/Sales 3.56
  • Price/Cash Flow 13.11
  • Price/Book 3.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.45 +6.37%
on 07/14/20
42.90 -4.67%
on 07/23/20
+2.39 (+6.21%)
since 07/10/20
3-Month
36.72 +11.38%
on 05/14/20
44.42 -7.92%
on 06/05/20
+0.57 (+1.41%)
since 05/11/20
52-Week
26.07 +56.89%
on 03/18/20
52.26 -21.74%
on 02/20/20
-4.81 (-10.52%)
since 08/09/19

Most Recent Stories

More News
Lateral Epicondylitis (Tennis Elbow) Market Outlook, 2026 with Profiles of Stryker, Smith & Nephew, Arthrex, Zimmer Biomet and More

, /PRNewswire/ -- The report has been added to offering.

CHGCF : 46.2500 (+2.78%)
PFE : 37.79 (-1.56%)
SKUNF : 16.0000 (unch)
SNN : 40.90 (unch)
SYK : 188.92 (+0.67%)
Cutera Appoints Rohan Seth as Chief Financial Officer

Cutera, Inc. (NASDAQ: CUTR) ("Cutera" or the "Company"), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced the appointment of Rohan Seth as the company's...

SNN : 40.90 (unch)
CUTR : 14.65 (+3.31%)
Surgical Stapling Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)

, /PRNewswire/ --

MDT : 100.72 (+0.34%)
SNN : 40.90 (unch)
Trauma & Extremities Devices Market Research Report by Device, by Injury, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ -- Read the full report: The Global Trauma & Extremities Devices Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.79%.Market...

ABT : 99.06 (-0.98%)
CAH : 53.04 (-0.04%)
MDT : 100.72 (+0.34%)
SIEGY : 68.1040 (-0.18%)
SNN : 40.90 (unch)
SYK : 188.92 (+0.67%)
Knee Replacement Market to Reach USD 12.48 Billion by 2027; Rising Awareness about Early Diagnosis to Boost Market, states Fortune Business Insights(TM)

The global knee replacement market is expected to reach USD 12.48 billion by 2027, exhibiting a CAGR of 4.3% during the forecast period. The growing cases of arthritis among the general population can...

SNN : 40.90 (unch)
Smith+Nephew announces new RI.HIP NAVIGATION for Total Hip Arthroplasty

, July 28, 2020 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the launch of the RI.HIP NAVIGATION for total hip arthroplasty (THA). This...

SNN : 40.90 (unch)
Smith+Nephew launches Real Intelligence and CORI™ Surgical System; next generation handheld robotics platform

, /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its Real Intelligence brand of enabling technology solutions, as well as its new...

SNN : 40.90 (unch)
Wound Care Market to Hit USD 24.55 Billion by 2027; Accountable to Presence of Well-Established Healthcare Infrastructure, says Fortune Business Insights(TM)

The global wound care market size is projected to showcase significant progress and earn USD 24.55 billion by 2027. This is accountable to the increasing prevalence of chronic diseases such as diabetes,...

MDT : 100.72 (+0.34%)
PLHNF : 310.0000 (-7.14%)
SNN : 40.90 (unch)
Diabetic Ulcer Treatment Market to Reach USD 13.53 Billion by 2027; Increasing Investment in Product Innovation will Increase Treatment Success Rate, says Fortune Business Insights(TM)

The global diabetic ulcer treatment market size is projected to reach USD 13.53 billion by the end of 2027. The increasing prevalence of diabetes will create several growth opportunities for the companies...

CNVVY : 10.0600 (-1.37%)
SNN : 40.90 (unch)
Smith+Nephew announces new milestone with its OXINIUM™ Advanced Bearing System implants surpassing two million procedures

, /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced that over two million patients have been treated with implants made from OXINIUM Technology -...

SNN : 40.90 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade SNN with:

Business Summary

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative...

See More

Key Turning Points

2nd Resistance Point 41.79
1st Resistance Point 41.35
Last Price 40.90
1st Support Level 40.68
2nd Support Level 40.45

See More

52-Week High 52.26
Fibonacci 61.8% 42.26
Last Price 40.90
Fibonacci 50% 39.17
Fibonacci 38.2% 36.07
52-Week Low 26.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar